GlassScriptPhysician profile
Steven A Rosen
NPI 1891768255
$4,080.43
in general payments reported to CMS, 2019-2025
44 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $147 · 2021: $988 · 2022: $1,797 · 2023: $335 · 2024: $28.83 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $812.48 | 2021-2025 | Botox, Ubrelvy |
| Amgen INC. | $372.33 | 2019-2022 | |
| Emd Serono, INC. | $243.41 | 2020-2023 | Mavenclad |
| Neurocrine Biosciences, INC. | $227.33 | 2022-2023 | Ongentys, Ingrezza |
| Ucb, INC. | $213.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $191.59 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $188.33 | 2019-2023 | Nuplazid |
| Alexion Pharmaceuticals, INC. | $181.31 | 2019-2023 | Ultomiris |
| Eisai INC. | $146.74 | 2022 | |
| Lundbeck LLC | $141.01 | 2019-2023 | Vyepti |
| Sk Life Science, INC. | $140.13 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $89.48 | 2019-2021 | |
| Grifols USA, LLC | $86.57 | 2019-2023 | Gamunex-C |
| Greenwich Biosciences, INC. | $79.19 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $73.92 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.